Clinical Features and Dynamics of T Cells-Related Markers in Immunocompetent Patients with Cytomegalovirus Hepatitis.

Takuya KomuraTakashi KagayaHideo TakayamaMasahiro YanagiTakatoshi YoshioSaiho SugimotoMichiko NishinoNoriaki OritaYoshiro AsahinaMasashi NishikawaShuichi KanekoMasashi Unoura

Published in: Canadian journal of gastroenterology & hepatology (2020)

CMV hepatitis in immunocompetent individuals has a satisfactory outcome, but occasionally results in complications in other organs. The sIL-2R level has potential as a surrogate marker of hepatic inflammation in immunocompetent patients with CMV hepatitis.

Keyphrases

oxidative stress
risk factors
climate change
diffuse large b cell lymphoma
drug induced